Aligos Therapeutics, Inc. Quarterly Current Ratio in % from Q2 2021 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Aligos Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q2 2021 to Q3 2024.
  • Aligos Therapeutics, Inc. Current Ratio for the quarter ending September 30, 2024 was 502 %, a 35.3% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 502 +131 +35.3% Sep 30, 2024
Q2 2024 488 +78.3 +19.1% Jun 30, 2024
Q1 2024 463 +8.43 +1.86% Mar 31, 2024
Q4 2023 412 -60.5 -12.8% Dec 31, 2023
Q3 2023 371 -132 -26.2% Sep 30, 2023
Q2 2023 410 -146 -26.3% Jun 30, 2023
Q1 2023 454 -127 -21.9% Mar 31, 2023
Q4 2022 473 -201 -29.8% Dec 31, 2022
Q3 2022 503 -257 -33.8% Sep 30, 2022
Q2 2022 556 -145 -20.7% Jun 30, 2022
Q1 2022 582 Mar 31, 2022
Q4 2021 674 Dec 31, 2021
Q3 2021 760 Sep 30, 2021
Q2 2021 701 Jun 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.